COPD clinical trials in New Jersey
8 studies for COPD are looking for participants at sites in New Jersey.
Cities in New Jersey
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Bioluminux Clinical Research - Hamilton, New Jersey- Site Number : 8400037, Hamilton
- Rutgers Institute For Infectious & Inflammatory Diseases (I3d)- Site Number : 8400093, Newark
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 23, 2026 · NCT07190222Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Sanmora Bespoke Clinical Research Solutions- Site Number : 8400144, East Orange
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 19, 2026 · NCT07190209This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization
- Inspira Medical Center Mullica Hill, Mullica Hill
RecruitingPhase 4
Ages 40 and older · All sexes · Updated Oct 16, 2026 · NCT07587658Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Moorestown
- GSK Investigational Site, Sewell
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 5, 2026 · NCT06961214A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Mullica Hill
- Research Site, Toms River
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 2, 2026 · NCT06283966A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Millville
- Research Site, Sewell
- Research Site, Toms River
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06883305COPD Exacerbation Follow Up
- Cooper University Health Care, Cherry Hill
RecruitingObservational study
Ages 40 and older · All sexes · Updated Sep 2, 2026 · NCT07118306Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Inspira Medical Center, Mullica Hill
RecruitingObservational study
Ages 50 and older · All sexes · Updated Aug 5, 2025 · NCT06122077From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.